110 related articles for article (PubMed ID: 9510879)
1. Effects of hormone replacement therapy on plasma glutathione S-transferase A1-1 concentrations in healthy postmenopausal women.
Mulder TP; Knapen MF; van der Mooren MJ; Demacker PD; Roes EM; Steegers EA; Peters WH
Clin Chem; 1998 Mar; 44(3):666-7. PubMed ID: 9510879
[No Abstract] [Full Text] [Related]
2. Differential effects on the androgen status of postmenopausal women treated with tibolone and continuous combined estradiol and norethindrone acetate replacement therapy.
Dören M; Rübig A; Coelingh Bennink HJ; Holzgreve W
Fertil Steril; 2001 Mar; 75(3):554-9. PubMed ID: 11239541
[TBL] [Abstract][Full Text] [Related]
3. Effects of continuous estrogen and estrogen-progestin replacement regimens on cardiovascular risk markers in postmenopausal women.
Davidson MH; Maki KC; Marx P; Maki AC; Cyrowski MS; Nanavati N; Arce JC
Arch Intern Med; 2000 Nov; 160(21):3315-25. PubMed ID: 11088095
[TBL] [Abstract][Full Text] [Related]
4. Anti-ischemic action of estrogen-progestogen continuous combined hormone replacement therapy in postmenopausal women with established angina pectoris: a randomized, placebo-controlled, double-blind, parallel-group trial.
Sanderson JE; Haines CJ; Yeung L; Yip GW; Tang K; Yim SF; Jorgensen LN; Woo J
J Cardiovasc Pharmacol; 2001 Sep; 38(3):372-83. PubMed ID: 11486242
[TBL] [Abstract][Full Text] [Related]
5. Effects of low-dose 17-beta-estradiol plus norethisterone acetate and tibolone on fasting plasma homocysteine levels in postmenopausal women.
Kaleli B; Yildirim B; Demir S; Alatas E
Acta Obstet Gynecol Scand; 2003 Dec; 82(12):1107-11. PubMed ID: 14616255
[TBL] [Abstract][Full Text] [Related]
6. Continuous combined and sequential estradiol and norethindrone acetate treatment of postmenopausal women: effect of plasma lipoproteins in a two-year placebo-controlled trial.
Munk-Jensen N; Ulrich LG; Obel EB; Nielsen SP; Edwards D; Meinertz H
Am J Obstet Gynecol; 1994 Jul; 171(1):132-8. PubMed ID: 8030688
[TBL] [Abstract][Full Text] [Related]
7. [Activelle - modern low-dose hormone replacement therapy for postmenopausal women].
Novo Nordisk.
Akush Ginekol (Sofiia); 2000; 39 Suppl 2():28-30. PubMed ID: 11188014
[No Abstract] [Full Text] [Related]
8. Transdermal progestins in hormone replacement therapy.
Jasonni VM; Naldi S; Amadori A; Santini D; Ceccarelli C; Possati G; D'Anna R; Leonardi J
Ann N Y Acad Sci; 1997 Sep; 828():352-7. PubMed ID: 9329856
[No Abstract] [Full Text] [Related]
9. Norethindrone acetate and estradiol-induced endometrial hyperplasia.
Kurman RJ; Félix JC; Archer DF; Nanavati N; Arce J; Moyer DL
Obstet Gynecol; 2000 Sep; 96(3):373-9. PubMed ID: 10960628
[TBL] [Abstract][Full Text] [Related]
10. Hormone replacement therapy: estrogen and progestin effects on plasma C-reactive protein concentrations.
Skouby SO; Gram J; Andersen LF; Sidelmann J; Petersen KR; Jespersen J
Am J Obstet Gynecol; 2002 May; 186(5):969-77. PubMed ID: 12015523
[TBL] [Abstract][Full Text] [Related]
11. Lipids and antioxidative effects of estradiol and sequential norethisterone acetate treatment in a 3-month randomized controlled trial.
Falkeborn M; Lithell H; Persson I; Vessby B; Naessén T
Climacteric; 2002 Sep; 5(3):240-8. PubMed ID: 12419082
[TBL] [Abstract][Full Text] [Related]
12. Effect of long-term hormone replacement therapy on plasma homocysteine in postmenopausal women: a randomized controlled study.
Madsen JS; Kristensen SR; Klitgaard NA; Bladbjerg EM; Abrahamsen B; Stilgren L; Jespersen J
Am J Obstet Gynecol; 2002 Jul; 187(1):33-9. PubMed ID: 12114885
[TBL] [Abstract][Full Text] [Related]
13. Influence of continuous combined estradiol-norethisterone acetate preparations on insulin sensitivity in postmenopausal nondiabetic women.
Kimmerle R; Heinemann L; Heise T; Bender R; Weyer C; Hirschberger S; Berger M
Menopause; 1999; 6(1):36-42. PubMed ID: 10100178
[TBL] [Abstract][Full Text] [Related]
14. Serum vascular endothelial growth factor concentrations in postmenopausal women: the effect of hormone replacement therapy.
Agrawal R; Prelevic G; Conway GS; Payne NN; Ginsburg J; Jacobs HS
Fertil Steril; 2000 Jan; 73(1):56-60. PubMed ID: 10632412
[TBL] [Abstract][Full Text] [Related]
15. The effect of continuous combined hormone replacement therapy on arterial reactivity in postmenopausal women with established angina pectoris.
Haines CJ; Yim SF; Sanderson JE
Atherosclerosis; 2001 Dec; 159(2):467-70. PubMed ID: 11730828
[TBL] [Abstract][Full Text] [Related]
16. A comparison of effects of sequential transdermal administration versus oral administration of estradiol plus norethisterone acetate on serum NO levels in postmenopausal women.
Kurtay G; Ozmen B; Erguder I
Maturitas; 2006 Jan; 53(1):32-8. PubMed ID: 16325022
[TBL] [Abstract][Full Text] [Related]
17. Effects of estrogen-progestin and raloxifene therapy on nitric oxide, prostacyclin and endothelin-1 synthesis.
Christodoulakos G; Panoulis C; Kouskouni E; Chondros C; Dendrinos S; Creatsas G
Gynecol Endocrinol; 2002 Feb; 16(1):9-17. PubMed ID: 11915588
[TBL] [Abstract][Full Text] [Related]
18. Effects on serum lipid and leptin levels of three different doses of norethisterone continuously combined with a fixed dose of 17beta-estradiol for nasal administration in postmenopausal women: a controlled, double-blind study.
Castelo-Branco C; Palacios S; Vázquez F; Villero J; Ferrer J; Ascaso C; Balasch J
Fertil Steril; 2007 Aug; 88(2):383-9. PubMed ID: 17561009
[TBL] [Abstract][Full Text] [Related]
19. Differing effects of low-dose estrogen-progestin therapy and pravastatin in postmenopausal hypercholesterolemic women.
Davis SR; Goldstat R; Newman A; Berry K; Burger HG; Meredith I; Koch K
Climacteric; 2002 Dec; 5(4):341-50. PubMed ID: 12626213
[TBL] [Abstract][Full Text] [Related]
20. A randomized, placebo-controlled trial of the effects of continuous combined hormone replacement therapy on coagulation and fibrinolytic systems in healthy postmenopausal women.
Salobir BG; Keber I; Vrabic L
Fertil Steril; 2002 Dec; 78(6):1178-83. PubMed ID: 12477508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
